A computational H5N1 neuraminidase model and its binding to commercial drugs

Molecular Simulation

Volumn 33, Issue 6, 2007, Pages 487-493

  Nimmanpipug, P ^a   Jitonnom, J ^a   Ngaojampa, C ^a   Hannongbua, S ^b   Lee, V S ^a  

^a CHIANG MAI UNIVERSITY   (Thailand)

^b CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Avian influenza; Flexible docking; H5N1; Molecular dynamics simulations; Structure refinement

Indexed keywords

CHEMICAL BONDS; COMPUTATION THEORY; DRUG PRODUCTS; MATHEMATICAL MODELS;

AVIAN INFLUENZA; FLEXIBLE DOCKING; MOLECULAR DYNAMICS SIMULATIONS; STRUCTURE REFINEMENT;

ENZYMES;

EID: 34548134462     PISSN: 08927022     EISSN: 10290435     Source Type: Journal    
DOI: 10.1080/08927020701255862     Document Type: Article

References (20)

1. K. Subbarao, A. Klimov, J. Katz, H. Regnery, W. Lim, H. Hall, M. Perdue, D. Swayne, C. Bender, J. Huang, M. Hemphill, T. Rowe, M. Shaw, X. Xu, K. Fukuda, N. Cox. Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science, 279, 393 (1998).
2. T. Horimoto, Y. Kawaoka. Pandemic threat posed by avian influenza A viruses. Clin. Microbiol. Rev., 14, 129 (2001).
3. B.J. Smith, P.M. Colman, M. Von Itzstein, B. Danylec, J.N. Varghese. Analysis of inhibitor binding influenza virus neuraminidase. Protein Sci., 10, 689 (2001).
4. C. Liu, M.C. Eichelberger, R.W. Compans, G.M. Air. Influenza type A virus neuraminidase does not play a role in viral entry, replication, assembly, or budding. J. Virol., 69, 1099 (1995).
5. P. Puthavathana, P. Auewarakul, P.C. Charoenying, K. Sangsiriwut, P. Pooruk, K. Boonnak, R. Khanyok, P. Thawachsupa, R. Kijphati, P. Sawanpanyalert. Molecular characterization of the complete genome of human influenza H5N1 virus isolates from Thailand. J. Gen. Virol., 86, 423 (2005).
6. J.D. Thompson, T.J. Gibson, F. Plewniak, F. Jeanmougin, D.G. Higgins. The CLUSTAL-X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res., 25, 4876 (1997).
7. A. Sali, T.L. Blundell. Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol., 234, 779 (1993).
8. D.A. Case, T.A. Darden, T.E. Cheatham III, C.L. Simmerling, J. Wang, R.E. Duke, R. Luo, K.M. Merz, B. Wang, D.A. Pearlman, M. Crowley, S. Brozell, V. Tsui, H. Gohlke, J. Mongan, V. Hornak, G. Cui, P. Beroza, C. Schafmeister, J.W. Cadwell, W.S. Ross, P.A. Kollman. AMBER 8, San Francisco, University of California (2004).
9. D.A. Pearlman, D.A. Case, J.W. Caldwell, W.S. Ross, T.E. Cheatham III, S. DeBoIt, D. Ferguson, G. Seibel, P. Kollman. AMBER, a package of computer programs for applying molecular mechanics, normal mode analysis, molecular dynamics and free energy calculations to simulate the structural and energetic properties of molecules. Comp. Phys. Commun., 91, 1 (1995).
10. R.A. Laskowski, M.W. MacArthur, D.S. Moss, J.M. Thornton. PROCHECK: a program to check the stereo chemical quality of protein structures. J. Appl. Cryst., 26, 283 (1993).
11. M.J. Sippl. Boltzmann's principle, knowledge based mean fields and protein folding, an approach to the computational determination of protein structures. J. Comput. Aided Mol. Design, 7, 473 (1993).
12. R. Luthy, J.U. Bowie, D. Eisenberg. Assessment of protein models with three-dimensional profiles. Nature, 356, 83 (1992).
13. I. Muegge, Y.C. Martin. A general and fast scoring function for protein-ligand interactions: a simplified potential approach. J. Med. Chem., 42, 791 (1999).
14. BioMedCache 2.0, CAChe work system pro 6.1, Fujitsu, Inc. CAChe Group. Fujitsu, 1250 E, Arques Avenue, Sunnyvale, CA 94085, USA.
15. N.R. Taylor, A. Cleasby, O. Singh, T. Skarzynski, A.J. Wonacott, P.W. Smith, S.L. Sollis, P.D. Howes, P.C. Cherry, R. Bethell, P. Colman, J. Varghese. Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 2. Crystallographic and molecular modeling study of complexes of 4-amino-4H-pyran-6-carboxamides and sialidase from influenza virus types A and B. J. Med. Chem., 41, 798 (1998).
16. Spartan'04 Windows. Wavefunction, Inc., 18401 Von Karman Avenue, Suite 370, Irvine, CA 92612, USA.
17. D.Q. Wei, Q.S. Du, H. Sun, K.C. Chou. Insights from modeling the 3D structure of H5N1 influenza virus neuraminidase and its binding interactions with ligands. Biochem. Biophys. Res. Commun., 344, 1048 (2006).
18. M.J. Jedrzejas, S. Singh, W.J. Brouillette, W.G. Laver, G.M. Air, M. Luo. Structures of aromatic inhibitors of influenza virus neuraminidase. Biochemistry, 34, 3144 (1995).
19. P. Bossart-Whitaker, M. Carson, Y.S. Babu, C.D. Smith, W.G. Laver, G.M. Air. Three-dimensional structure of influenza A N9 neuraminidase and its complex with the inhibitor 2-deoxy 2,3-dehydro-N-acetyl neuraminic acid. J. Mol. Biol., 232, 1069 (1993).
20. P.M. Colman, W.R. Tulip, J.N. Varghese, P.A. Tulloch, A.T. Baker, W.G. Laver, G.M. Air, R.G. Webster. Three-dimensional structures of influenza virus neuraminidase-antibody complexes. Philos. Trans. R. Soc. Lond. B Biol. Sci., 323, 511 (1989).